[Medical Newspaper/Daily Newspaper = Reporter Oh In-gyu] AdipoLABs (CEO Han Sung-ho), a domestic cancer treatment device manufacturer, announced that Mongolian Minister of Health and Welfare Sodnom Chinzorig recently visited its headquarters to discuss the introduction of its high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’.

     

This visit was made by AdipoLABs, a company that sponsors IVRA (Co-CEOs Sung-ho Han, Seung-mo Yoo, and Hong-seok Jang, IVRA Chairman), for the purpose of cancer treatment and clinical trials. It is believed this visit is the result of the company’s consistent donations, so far.

As a result, the Ministry of Health and Welfare of Mongolia has also become fascinated, and Minister Sodnom Chinzorig expressed interest in introducing the high-frequency hyperthermia cancer treatment device REMISSION 1℃ to the country's national cancer center, leading to a meeting with CEO Han Sung-ho. REMISSION 1℃ has consistently proven its effectiveness through successful clinical treatment cases at the IVRA International Academic Seminar.

On this day, Minister Sodnom Chinzorig requested cooperation between domestic medical staff and the IVRA Association for the treatment of Mongolian cancer patients through REMISSION 1℃. To this end, Han Sung-ho, CEO of AdipoLABs, agreed to provide complete support to the Mongolian government to introduce high-frequency hyperthermia cancer treatment devices by donating the first device for the Mongolian government's domestic approval and clinical trials.

As a follow-up, AdipoLABs plans to have CEO Han Sung-ho visit Mongolia at the invitation of the Mongolian government to continue related discussions in April or May to promote the donation and introduction of REMISSION 1℃ to Mongolia.

Sung-ho Han, CEO of AdipoLABs, said, “REMISSION 1℃ cancer treatment device, which had received abundant amount of attention in Southeast Asia, will now be of great help to the development of domestic medical devices as its technology has been spread to China and Mongolia as well.” Sodnom Chinzorig, Ministry of Health and Welfare of Mongolia continued. “The minister’s visit will serve as an opportunity to further raise the status of Korea’s medical technology,” he emphasized.

Meanwhile, the International Virus Research Alliance (IVRA), an association formed in response to the COVID pandemic, is holding international conferences every year as a non-profit medical association. Currently, its members consist of about 200 people from home and abroad. IVRA is a non-profit medical association that holds international conferences every year. IVRA shares expert knowledge on treatment and holds related seminars every year.

IVRA is establishing itself as an association that presents future directions for cancer treatment and shares domestic medical technology globally. Mongolian medical staff also promised to participate in the IVRA International Conference to be held at Seoul St. Mary's Hospital on June 9th.

아디포랩스, 몽골 보건복지부와 ‘리미션1℃’ 도입 논의 < 의료기기·IT < 기사본문 - 의학신문 (bosa.co.kr)

AdipoLABs discusses introduction of ‘REMISSION 1℃’ with Mongolian Ministry of Health and Welfare < Medical devices/IT < Text of article - Medical Newspaper (bosa.co.kr)